Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.5K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.6K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-guided compound prioritization strategy for virtual screening identifies putative binders for the nuclear receptor LRH-1.

bioRxiv : the preprint server for biology·2026
Same author

Profiling the CFTR Variant Selectivity and Off-Target Interactions of VX-121.

bioRxiv : the preprint server for biology·2026
Same author

Molecular basis of CXC chemokine receptor 3 ligand multispecificity.

Science advances·2026
Same author

The pathway-independent positive allosteric modulator C1 allows for the identification of active Y<sub>4</sub> receptor relevant positions.

Cellular and molecular life sciences : CMLS·2026
Same author

Superwater as a generative AI framework to predict water molecule positions on protein structures.

Communications chemistry·2025
Same author

Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies.

Nature communications·2025

Related Experiment Video

Updated: Dec 6, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.9K

Assessing multiple score functions in Rosetta for drug discovery.

Shannon T Smith1,2, Jens Meiler2,3,4

  • 1Chemical and Physical Biology Program, Vanderbilt University, Nashville, Tennessee, United States of America.

Plos One
|October 12, 2020
PubMed
Summary
This summary is machine-generated.

RosettaLigand score functions show strong performance in small molecule drug discovery benchmarks, ranking highly in scoring, docking, and screening tests compared to other software. However, newer Rosetta score functions demonstrate decreased performance in these small molecule applications.

More Related Videos

A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors
08:46

A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors

Published on: December 2, 2022

2.6K
Pooled CRISPR-Based Genetic Screens in Mammalian Cells
09:05

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

22.8K

Related Experiment Videos

Last Updated: Dec 6, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.9K
A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors
08:46

A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors

Published on: December 2, 2022

2.6K
Pooled CRISPR-Based Genetic Screens in Mammalian Cells
09:05

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

22.8K

Area of Science:

  • Computational biology
  • Structural bioinformatics
  • Drug discovery

Background:

  • Rosetta is a versatile computational software suite for macromolecular structure prediction and design.
  • It includes protocols for small molecule tasks crucial in drug discovery and enzyme design.

Purpose of the Study:

  • To benchmark RosettaLigand score functions and protocols against the CASF-2016 dataset.
  • To evaluate Rosetta's performance in scoring, ranking, docking, and virtual screening of small molecules.

Main Methods:

  • Comparison of RosettaLigand score functions with results from the CASF-2016 benchmark.
  • Evaluation of scoring, ranking, ligand docking, and virtual screening capabilities.
  • Full sampling ligand docking tests to simulate typical use cases.

Main Results:

  • The original RosettaLigand score function ranked among the top software in CASF-2016 tests (2/34 for scoring).
  • RosettaLigand demonstrated strong performance in scoring, ranking, docking, and screening.
  • Newer Rosetta score functions showed reduced performance on small molecule benchmarks compared to older versions.

Conclusions:

  • The original RosettaLigand score function is highly effective for small molecule tasks within drug discovery.
  • There is a noted decline in performance for more recent Rosetta score functions in small molecule applications.
  • Continuous benchmarking on the Rosetta server will monitor performance during ongoing development.